Hong Kong-based pharmaceutical company Aptorum Group Limited is seeking to raise up to US$30 million in an initial public offering of its class A ordinary shares in the U.S., according to a statement released by the company yesterday.
Hong Kong-Based Pharma Aptorum Seeks To Raise Up To $30M In US IPO appeared first on ...
This news article comes via China Money Network, who is the copyright owner of this information and news. FintekAsia.com has licensed the rights to this article and any republication or re-distribution in whole or in part of this content is strictly prohibited without the express consent of